ETC
Exchange Traded Concepts’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Buy |
2,518
+113
| +5% | +$14.2K | ﹤0.01% | 977 |
|
|
2025
Q1 | $329K | Buy |
2,405
+119
| +5% | +$16.3K | 0.01% | 821 |
|
|
2024
Q4 | $350K | Buy |
2,286
+624
| +38% | +$95.4K | 0.01% | 827 |
|
|
2024
Q3 | $322K | Buy |
1,662
+1,626
| +4,517% | +$315K | 0.01% | 820 |
|
|
2024
Q2 | $8.35K | Sell |
36
-254
| -88% | -$58.9K | ﹤0.01% | 1105 |
|
|
2024
Q1 | $62.5K | Buy |
290
+282
| +3,525% | +$60.8K | ﹤0.01% | 949 |
|
|
2023
Q4 | $2.07K | Sell |
8
-4
| -33% | -$1.04K | ﹤0.01% | 1201 |
|
|
2023
Q3 | $3.08K | Buy |
12
+4
| +50% | +$1.03K | ﹤0.01% | 1234 |
|
|
2023
Q2 | $2.28K | Sell |
8
-1
| -11% | -$285 | ﹤0.01% | 1276 |
|
|
2023
Q1 | $2.5K | Sell |
9
-10,398
| -100% | -$2.89M | ﹤0.01% | 1083 |
|
|
2022
Q4 | $2.88M | Buy |
10,407
+10,048
| +2,799% | +$2.78M | 0.08% | 156 |
|
|
2022
Q3 | $96K | Buy |
359
+118
| +49% | +$31.6K | ﹤0.01% | 754 |
|
|
2022
Q2 | $49K | Buy |
241
+129
| +115% | +$26.2K | ﹤0.01% | 910 |
|
|
2022
Q1 | $24K | Sell |
112
-22,905
| -100% | -$4.91M | ﹤0.01% | 1013 |
|
|
2021
Q4 | $5.52M | Buy |
23,017
+7,117
| +45% | +$1.71M | 0.11% | 122 |
|
|
2021
Q3 | $4.5M | Buy |
15,900
+15,471
| +3,606% | +$4.38M | 0.11% | 113 |
|
|
2021
Q2 | $149K | Buy |
429
+22
| +5% | +$7.64K | ﹤0.01% | 766 |
|
|
2021
Q1 | $114K | Sell |
407
-35,372
| -99% | -$9.91M | ﹤0.01% | 713 |
|
|
2020
Q4 | $8.76M | Sell |
35,779
-10,767
| -23% | -$2.64M | 0.41% | 37 |
|
|
2020
Q3 | $13.2M | Buy |
46,546
+11,419
| +33% | +$3.24M | 0.75% | 22 |
|
|
2020
Q2 | $9.4M | Buy |
35,127
+30,295
| +627% | +$8.11M | 1.56% | 5 |
|
|
2020
Q1 | $1.53M | Buy |
4,832
+4,755
| +6,175% | +$1.5M | 0.83% | 31 |
|
|
2019
Q4 | $23K | Buy |
+77
| New | +$23K | ﹤0.01% | 289 |
|